Document:

imsc8k_ex10-1.htm

Exhibit 10.1

 

 

OMNIBUS SEVENTH AMENDMENT TO CREDIT AGREEMENT AND

NINTH AMENDMENT TO NOTE AND WARRANT PURCHASE AGREEMENT

 

This Omnibus Seventh Amendment to Credit Agreement and Ninth Amendment to Note and Warrant Purchase Agreement (“Amendment”) is made as of the 13th day of October, 2011 between Implant Sciences Corporation, a Massachusetts corporation (the “Company”), and DMRJ Group LLC, a Delaware limited liability company (the “Lender”).

BACKGROUND

 

A. Company and Lender are parties to a certain Note and Warrant Purchase Agreement dated as of December 10, 2008 (as modified or amended from time to time, including, without limitation, as amended by that certain Omnibus Waiver and First Amendment to Credit Agreement and Third Amendment to Note and Warrant Purchase Agreement dated as of January 12, 2010 (the “First Omnibus Amendment”), that certain Omnibus Second Amendment to Credit Agreement and Fourth Amendment to Note and Warrant Purchase Agreement dated as of April 23, 2010 (the “Second Omnibus Amendment”), that certain Omnibus Third Amendment to Credit Agreement and Fifth Amendment to Note and Warrant Purchase Agreement dated as of September 30, 2010 (the “Third Omnibus Amendment”), that certain Omnibus Fourth Amendment to Credit Agreement and Sixth Amendment to Note and Warrant Purchase Agreement dated as of March 30,  2011 (the “Fourth Omnibus Amendment”), that certain Omnibus Fifth Amendment to Credit Agreement and Seventh Amendment to Note and Warrant Purchase Agreement dated as of April 7, 2011 (the “Fifth Omnibus Amendment”) and that certain Omnibus Sixth Amendment to Credit Agreement and Eighth Amendment to Note and Warrant Purchase Agreement dated as of September 29, 2011 (the “Sixth Omnibus Amendment” and, collectively,  the “Purchase Agreement”), pursuant to which, among other things, Lender purchased that certain Amended and Restated Senior Secured Convertible Promissory Note dated March 12, 2009 in the original aggregate principal amount of $5,600,000 (the “March 2009 Note”).

 

B. Pursuant to the Purchase Agreement, Lender subsequently purchased that certain Senior Secured Promissory Note dated July 1, 2009 in the original aggregate principal amount of $1,000,000 (the “July 2009 Note” and together with the March 2009 Note, the “Term Notes” and each a “Term Note”).

 

C.   The Purchase Agreement and all instruments, documents and agreements executed in connection therewith, or related thereto, including, without limitation, the March 2009 Note and the July 2009 Note, are referred to herein collectively as the “Purchase Documents”.

 

D. Company and Lender are also parties to a certain Credit Agreement dated September 4, 2009 (as modified or amended from time to time, including, without limitation, as amended by the First Omnibus Amendment and the Second Omnibus Amendment, the “Credit Agreement”), pursuant to which, among other things, the Company executed and delivered to Lender that certain Promissory Note dated September 4, 2009 in the original aggregate principal amount of $3,000,000 (as amended by that certain Amended and Restated Promissory Note dated January 12, 2010 in the

 

 

  

  

  

 

original aggregate principal amount of $5,000,000 and that certain Amended and Restated Promissory Note dated as of April 23, 2010 but effective as of April 7, 2010 in the original aggregate principal amount of $10,000,000, that certain Amended and Restated Promissory Note dated as of March 30, 2011 in the original aggregate principal amount of $15,000,000, and that certain Amended and Restated Promissory Note dated as of September 29, 2011 in the original aggregate principal amount of $23,000,000, the “Revolver Note” and together with the March 2009 Note and the July 2009 Note, each a “Note” and collectively, the “Notes”).

 

E.   The Credit Agreement and all instruments, documents and agreements executed in connection therewith, or related thereto, including, without limitation, the Revolver Note, are referred to herein collectively as the “Credit Documents” and together with the Purchase Documents, each a “Transaction Document” and collectively, the “Transaction Documents”.

 

F. Company has requested that Lender modify certain definitions, terms and conditions in the Transaction Documents, and Lender is willing to do so on the terms and conditions hereafter set forth.

 

G. All capitalized terms not otherwise defined herein shall have the meaning ascribed thereto in the Transaction Documents.

 

NOW, THEREFORE, with the foregoing Background incorporated by reference and made a part hereof and intending to be legally bound, the parties agree as follows:

 

1. Amendments to the Transaction Documents.  Upon the effectiveness of this Amendment, Section 1(c) of the Sixth Omnibus Amendment is hereby deleted and of no further force or effect.

 

2. Representations and Warranties.  Company represents and warrants to Lender that:

 

(a) The Company and the Guarantors (as applicable) have the requisite corporate power and authority to enter into and perform this Amendment in accordance with the terms hereof.  The execution, delivery and performance of this Amendment by the Company and the consummation by it of the transactions contemplated hereby have been duly and validly authorized by all necessary corporate action, no further consent or authorization of the Company, its Board of Directors, stockholders or any other third party is required.  When executed and delivered by the Company and the Guarantors, this Amendment shall constitute a valid and binding obligation of the Company and the Guarantors enforceable against the Company and the Guarantors in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, reorganization, moratorium, liquidation, conservatorship, receivership or similar laws relating to, or affecting generally the enforcement of, creditor’s rights and remedies or by other equitable principles of general application.

 

(b) This Amendment is valid, binding, and enforceable against the Company and the Guarantors in accordance with its terms.

 

(c) Upon the effectiveness of this Amendment, no default or Event of Default is outstanding under any of the Transaction Documents.

 

 

  

2

  

 

3. Effectiveness Conditions.  This Amendment shall be effective upon the execution and delivery by Company and each Person who delivered a Guarantee to Lender in connection with the Transaction Documents (each a “Guarantor” and collectively, the “Guarantors”) to Lender of this Amendment.

 

4. Expenses.  The Company shall pay any and all costs, fees and expenses of Lender (including without limitation, attorneys’ fees) in connection with this Amendment and the transaction contemplated hereby.  The Company shall pay such amounts upon execution of this Amendment.

 

5. No Waiver.  Lender reserves all of its rights and remedies arising with respect to any and all defaults or events of defaults under the Transaction Documents that may be in existence on the date hereof, regardless of whether such defaults or events of default have been identified, or which may occur in the future.  Lender has not modified, is not waiving and has not agreed to forbear in the exercise of, any of its present or future rights and remedies.  No action taken or claimed to be taken by Lender will constitute such a waiver, modification or agreement to forbear.  This Amendment does not obligate Lender to agree to any other extension or modification of the Transaction Documents nor does it constitute a course of conduct or dealing on behalf of Lender or a waiver of any other rights or remedies of Lender except as and only to the extent expressly set forth herein.  No omission or delay by Lender in exercising any right or power under the Transaction Documents, this Amendment or any related instruments, agreements or documents will impair such right or power or be construed to be a waiver of any default or Event of Default or an acquiescence therein, and any single or partial exercise of any such right or power will not preclude other or further exercise thereof or the exercise of any other right, and no waiver will be valid unless in writing and then only to the extent specified.

 

6. Ratification of Loan Documents.  Except as expressly set forth herein, all of the terms and conditions of the Purchase Agreement, the Credit Agreement and the other Transaction Documents are hereby ratified and confirmed and continue unchanged and in full force and effect.  All references to any of the Transaction Documents shall mean the applicable Transaction Document as modified by this Amendment.

 

7. Confirmation of Indebtedness.  Company confirms and acknowledges that as of the close of business on October 12, 2011, Company was indebted to Lender without any deduction, defense, setoff, claim or counterclaim, of any nature, in the aggregate principal and interest in the amount of $24,217,000 of which $4,661,000 is due on account of the March 2009 Note, $1,432,000 is due on account of the July 2009 Note and $18,524,000 is due on account of Advances (as defined in the Credit Agreement), plus all fees, costs and expenses incurred to date in connection with the Purchase Agreement, the Credit Agreement and the other Transaction Documents.

 

8. Collateral.  Company and Guarantors hereby confirm and agree that all security interests and liens granted to Lender pursuant to the Transaction Documents continue in full force and effect and shall continue to secure the Obligations (as defined in the Security Agreements (as defined in the Purchase Agreement and as defined in the Credit Agreement)), including all liabilities and obligations (primary, secondary, direct, contingent, sole, joint or several) due or to become due, or that are now or may be hereafter contracted or acquired, or owing, under the Notes and any other instruments, agreements or other documents executed and/or delivered in connection herewith or therewith, in each case, whether now or hereafter existing, voluntary or involuntary, direct or

 

 

  

3

  

 

indirect, absolute or contingent, liquidated or unliquidated, whether or not jointly owed with others, and whether or not from time to time decreased or extinguished and later increased, created or incurred, and all or any portion of such obligations or liabilities that are paid, to the extent all or any part of such payment is avoided or recovered directly or indirectly from Lender as a preference, fraudulent transfer or otherwise as such obligations may be amended, supplemented, converted, extended or modified from time to time.

 

9. Acknowledgment of Guarantors.  By execution of this Amendment, each Guarantor hereby acknowledges the terms and conditions of this Amendment and confirms that Guarantors jointly and severally and absolutely and unconditionally guarantee, as surety, all of Guarantied Obligations (as defined in the Guaranty from Guarantors to Lender dated December 10, 2008 and in the Guaranty from Guarantors to Lender dated September 4, 2009) including all liabilities and obligations (primary, secondary, direct, contingent, sole, joint or several) due or to become due, or that are now or may be hereafter contracted or acquired, or owing, under the A&R Revolver Note and covenants that each such Guaranty remains unchanged and in full force and effect and shall continue to cover the existing and future Obligations of Company to Lender.

 

10. Governing Law.  This Amendment shall be governed by and construed in accordance with the internal laws of the State of New York, without giving effect to any of the conflicts of law principles which would result in the application of the substantive law of another jurisdiction.  This Amendment shall not be interpreted or construed with any presumption against the party causing this Amendment to be drafted.

 

11. Signatories:  Each individual signatory hereto represents and warrants that he or she is duly authorized to execute this Amendment on behalf of his or her principal and that he or she executes the Amendment in such capacity and not as a party.

 

12. Duplicate Originals:  Two or more duplicate originals of this Amendment may be signed by the parties, each of which shall be an original but all of which together shall constitute one and the same instrument.  This Amendment may be executed in counterparts, all of which counterparts taken together shall constitute one completed fully executed document.  Signature by facsimile or PDF shall bind the parties hereto.

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

  

4

  

IN WITNESS WHEREOF, the parties have executed this Amendment the day and year first above written.

 

	
COMPANY:

	
IMPLANT SCIENCES CORPORATION

 

By: /s/ Glenn D. Bolduc

Name: Glenn D. Bolduc

Title: Chief Executive Officer

 

	
GUARANTORS:

	
C ACQUISITION CORP.

 

 

By: /s/ Glenn D. Bolduc

Name: Glenn D. Bolduc

Title: President

 

	  	
ACCUREL SYSTEMS INTERNATIONAL CORPORATION

 

 

By: /s/ Glenn D. Bolduc

Name: Glenn D. Bolduc

Title: President

 

	  	
IMX ACQUISITION CORP.

 

 

By: /s/ Glenn D. Bolduc

Name: Glenn D. Bolduc

Title: President

 

	
LENDER:

	
DMRJ GROUP LLC

 

By: /s/ Daniel Small

Name: Daniel  Small

Title: Managing Director

 

 

 

 

[SIGNATURE PAGE TO OMNIBUS AMENDMENT]Exhibit 10.1

 

SEPARATION AGREEMENT AND RELEASE

 

This Separation Agreement and Release (the “Agreement”) is made and entered into by and between Summer Infant, Inc. and its subsidiaries, including, without limitation, Summer Infant (USA), Inc. (collectively, the “Company”) and Jeffrey L. Hale (“Hale”).

 

RECITALS

 

A.                                   Hale has been employed by the Company as Chief Operating officer since July 13, 2009.

 

B.                                     Hale’s employment at the Company has been terminated as a result of his voluntary resignation, effective October 13, 2011, at which time Hale will be relieved of all responsibilities as a Company employee.

 

C.                                     The parties wish to settle and compromise fully and finally any and all claims Hale has or purports to have against the Company and others, including, but not limited to, those arising out of Hale’s employment and the termination of his employment, on the terms and conditions set forth in this Agreement.

 

COVENANTS

 

In consideration of the mutual promises in this Agreement, the parties agree as follows:

 

1.             Termination.  Hale and the Company agree that Hale’s employment is terminated as of October 13, 2011 (the “Termination Date”) and he shall be deemed to have resigned from all offices held in the Company or any of its subsidiaries on such date.  Hale will be paid all earned wages, accrued but unpaid benefits relating to vacations, other perquisites, and reimbursements through the Termination Date within fourteen (14) days from the date hereof.   In addition, Hale will receive:

 

(a)           For a period of six (6) months following the Termination Date, the Company shall pay to Hale his base salary annualized at the rate of $275,000 in equal installments on such dates as his base salary would otherwise be paid by the Company in accordance with its regular payroll procedures, less applicable deductions and withholdings.

 

(b)           For a period of six (6) months following the Termination Date, the Company agrees to continue any applicable medical and dental insurance in which Hale and his dependants, if any, are enrolled on the Termination Date at the same coverage levels and cost to Hale in effect on the Termination Date.  Hale will continue to be responsible for the same premiums he currently pays which will be deducted from the salary continuation payments described in Section 1(a).  If the Company’s insurance company informs the Company that Hale cannot continue under the applicable plans after the Termination Date, the Company will cooperate with Hale to provide coverage pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1986, as amended (COBRA).  Notwithstanding the foregoing, during the six (6) months the Company is obligated to continue the medical and dental benefits under the terms of this Section 1(c), such benefits shall be discontinued immediately if any required premium is not paid in full on time, Hale becomes covered under another group health plan, Hale becomes entitled to Medicare benefits (under Part A, Part B, or both), or the Company ceases to

 

 

provide any group health plan for its employees.  Continuation may also be terminated if for any reason the plan providing such coverage would terminate coverage of a participant or an eligible dependent.

 

(c)           The Company shall pay for six (6) months following the Termination Date the premiums for Hale for life insurance and disability coverage as provided to him as of the Termination Date under either the current policies, if possible, or comparable standard policies implemented for Company employees.  The parties acknowledge and agree that Hale’s participated in the Company’s 401(k) plan, and his rights to benefits under that plan following the Termination Date will be governed by the terms of that plan.

 

(d)           The following incentive awards will continue to vest through their respective scheduled vesting date as follows:  restricted stock grant awarded March 1, 2011, of which 3,402 shares vested on issue date and 3,402 shares are scheduled to vest on March 1, 2012 (the “Stock Award”).  Promptly after March 1, 2012, the Company will deliver or cause to be delivered the 3,402 vested shares under the Stock Award.   All other incentive awards vested as of the Termination Date held by Hale may be exercised according to their original expiration terms, and thereafter shall be deemed null and void.  All other unvested incentive awards and options as of the Termination Date held by Hale will be deemed terminated and of no further effect.

 

(e)           The Company will provide Hale with twelve (12) months of executive-level outplacement services from one or more firms chosen by the Company.

 

(f)  If Hale has not commenced new employment  prior to the expiration of the six (6) month period referenced in Sections  1 (a) , (b) and (c) above, then Hale shall notify Mark Strozik, Vice President, Human Resources for  the Company in writing, at the address set forth in Section 10, that he has not commenced new employment.  Upon receipt of such written notice, the Company agrees to continue to provide to Hale for a period of three (3) additional months (“Enhanced Severance Period”) his: (i) base salary in accordance with Section 1 (a), (ii) pay the Company’s share of his medical and dental benefits in accordance with Section 1 (b) and pay the premiums on Hale’s life insurance and disability coverage in accordance with Section 1 (c) above.

 

(g) In consideration of Section 1 (f) above,  Hale covenants and agrees that he will immediately  notify the Company, in writing, if and when he has begun new employment at any time  during the Enhanced Severance Period. If Hale begins new employment during the Enhanced Severance Period then:

 

(i)            Hale’s severance pay set forth in Section 1 (f) (i) will end and he will be obligated to repay the Company any severance paid by the Company for periods after Hale began the new employment but before Hale notified the Company of such new employment; and

 

(ii)           Hale’s continuance in any life, disability, medical and dental insurance plans shall end when the new employment begins and further, Hale shall be obligated to repay to the Company  any premiums paid by the Company for life and

 

2

 

disability coverage and the Company’s share of the cost for the medical and dental coverage paid after Hale begins  any new employment but before Hale has notified the Company of his new employment.

 

2.             Severance Consideration.  In consideration for the execution, delivery, and non-revocation of this Agreement by Hale, the Company will accept Hale’s voluntary resignation, will provide the consideration set forth in Section 1 of this Agreement, and shall agree to enter into the Release as set forth in Section 4 of this Agreement (the “Severance Consideration”).

 

3.             No Entitlement. Hale understands and agrees that he is receiving this Severance Consideration in exchange for this Release, and Hale is not otherwise entitled to this Severance Consideration.

 

4.             Release.  The Release set forth in this section is effective as of the Effective Date of this Agreement.

 

(a)           Hale for himself and, as applicable, his agents, attorneys, successors, and assigns, hereby knowingly and voluntarily irrevocably and unconditionally releases the Company, its predecessors, parent, subsidiaries, affiliated entities, and the past and present officers, directors, employees, fiduciaries, shareholders, agents, successors, representatives and assigns of each and all of them, and all persons acting by, through, under or in concert with them (each a “Releasee” and collectively referred to as “Releasees”), from any and all claims, charges, complaints, liabilities, and obligations of any nature whatsoever, which Hale may have against the Company or any of the Releasees, whether now known or unknown, and whether asserted or unasserted, arising from any event or omission occurring prior to the Termination Date of this Agreement.

 

(b)           Without limiting the foregoing, this release includes any and all claims arising out of or which could arise out of the employment relationship between Hale and the Company, all claims arising out of Hale’s separation from employment, all claims arising from any failure to reemploy Hale, all claims and damages relating to race, sex, national origin, handicap (disability), religion, gender identity or expression, sexual orientation and benefits, genetic information, marital status  and all employment discrimination claims, including but not limited to: (i) any and all claims under Title VII of the Civil Rights Act of 1964,  the Americans with Disabilities Act of 1990, Section 1981 of the Civil Rights Act of 1866, the Age Discrimination in Employment Act as amended by the Older Workers Benefit Protection Act, the Equal Pay Act, the Family and Medical Leave Act, the Worker Adjustment and retraining Notification Act (“WARN”), the Fair Labor Standards Act, the Employee Retirement Income Security Act (ERISA), COBRA, Section 806 of the Corporate and Criminal Fraud Accountability Act of 2002, the Genetic Information Nondiscrimination Act, the Rhode Island Parental and Family Medical Leave Act, the Rhode Island Fair Employment Practices Act, the Rhode Island Civil Rights Act of 1990, the Rhode Island Sexual Harassment, Education and Training Act, the Rhode Island Wage Discrimination Based on Sex Law, the Rhode Island Whistleblowers Protection Act, the National Labor Relations Act, as amended, state and local civil rights laws, Rhode Island wage payment laws, and any and all similar laws in other states; (ii) all wrongful discharge claims, common law tort, defamation, breach of contract and other

 

3

 

common law claims; (iii) any and all Executive Orders (governing fair employment practices) which may be applicable to the Company; and (iv) any other provision or theory of law or equity.  Hale understands and acknowledges that Title VII of the Civil Rights Act of 1964, ERISA, and state and local civil right laws, provide Hale the right to bring actions against the Company if, among other things, Hale believes he has been discriminated against on the basis of race, ancestry, color, religion, sex, national origin, medical condition, sexual orientation, disability, or benefit eligibility.  With full understanding of the right afforded under these Acts, Hale agrees that he will not file any action against the Company or any Releasee based upon any alleged violation of these Acts or under any other theory of law or statute, including but not limited to, back pay, front pay, attorney’s fees, damages, interest, waiting time, penalties, reinstatement, or injunctive relief that could be assessed by any federal, state or local court, any administrative agency, or any other forum with competent jurisdiction.  This release may be pled as a complete bar and defense to any claim brought with respect to the matters released in this Agreement.

 

(c)           Hale acknowledges and agrees that the consideration he is receiving under this Agreement is sufficient consideration to support the release of all entities and persons identified in Section 4 of this Agreement, and that said consideration is in addition to anything of value to which Hale is entitled.

 

(d)           Hale agrees and represents that he has not filed, or caused to be filed, any claim or charge with any adjudicative body, regulatory body, or agency arising out of his employment or termination of employment. Hale further affirms that he has no known workplace injuries or occupational diseases.

 

(e)           Hale specifically understands and acknowledges that the Age Discrimination in Employment Act of 1967, as amended, provides him the right to bring a claim against the Company if he believes that he has been discriminated against on the basis of age. Hale understands the rights afforded under this Act and agrees that he will not file any such claim or action against the Company or any Releasee, including, but not limited to, back pay, front pay, attorney’s fees, damages, reinstatement, or injunctive relief.

 

(f)            To the fullest extent permitted by law, at no time subsequent to the execution of this Agreement will Hale pursue, or cause or knowingly permit the prosecution, in any state, federal or foreign court, or before any local, state, federal or administrative agency, or any other tribunal, any charge, claim or action of any kind, nature and character whatsoever, known or unknown, which Hale may now have, has ever had, or in the future may have against any Releasee, which is based in whole or in part on any matter covered by this Agreement.

 

5.             Communications; Return of Property.  From and after the Termination Date, Hale shall not (a) represent himself as an employee, officer, director or representative of the Company or any of its subsidiaries or attempt to conduct business in the name or on behalf of the Company or any of its subsidiaries; (b) send e-mails directed to anyone on the Company’s e-mail system; or (c) visit the Company’s premises without consent of the Company.  Upon the Termination Date, Hale agrees to promptly return all items of Company property he has or over which he has control, including but not limited to all keys, records, designs, lab top computer, patents, business plans, financial statements, manuals, memoranda, lists, and other property delivered to or compiled by Hale by or on behalf of the Company (or its subsidiaries) or its representatives, vendors, or customers that pertain to the business of the Company (or its subsidiaries), all

 

4

 

equipment belonging to the Company, all code and computer programs and information of whatever nature, tools, manuals, and any and all other materials, documents or information, including but not limited to confidential information in his possession or control, and that he will retain no copies thereof.  Likewise, all correspondence, reports, records, charts, advertising materials, and other similar data pertaining to the business, activities or future plans of the Company (or its subsidiaries) that has been collected by Hale shall be delivered promptly to the Company upon the Termination Date.

 

6.             Trade Secrets/Confidentiality.  Hale acknowledges that during the course of his employment, he had access to various trade secrets, whether in existence or proposed, and confidential information of the Company.  Such information includes, but is not limited to, business plans, schematics, blue prints, product information, software, hardware, financial information, manuals, training programs, profit margins, marketing plans, customer information, and the specific terms of the Company’s relationships or agreements with its respective significant vendors or customers. Hale agrees that he shall not disclose such information or use it in any way, at any time in the future, except to the extent such information becomes publicly available through lawful and proper means, or to the extent that Hale is required to disclose such information pursuant to subpoena.  If such information is requested pursuant to a subpoena, Hale must give immediate and timely notice to the Company, so that the Company has a reasonable opportunity to seek judicial relief to preclude disclosure, if necessary.  Without limitation, the prohibition in this section includes Hale’s use of such information to directly or indirectly solicit any manufacturer, manufacturer’s representative, distributor, or customer of the Company or any of its subsidiaries, and Hale’s use of such information to directly or indirectly interfere with the advantageous business relationship(s) between the Company and any of its customers, vendors or suppliers.

 

7.             Restrictive Covenants.

 

(a)           Notwithstanding the restrictions set forth in Section 6 of this Agreement, for a period of six (6) months from the Termination Date:

 

i.              Hale will not, and will not permit any person subject to his direction or control to, directly or indirectly, whether alone or in association with others, as principal, officer, agent, consultant, employee, director or owner of any corporation, partnership, association or other entity, or through the investment of capital, lending of money or property, rendering of services or otherwise, engage in, influence, control, have an interest in or otherwise become actively involved with any business that competes with the Company.  Hale acknowledges that the business of the Company is national and international in scope, as its current and anticipated customers and suppliers are located throughout the United States and abroad, and that it is therefore reasonable that the restrictions set forth in this Section 7(a)(i) not be limited to any specified geographic area.

 

ii.             Hale will not directly or indirectly attempt to encourage, induce or otherwise solicit, directly or indirectly, any employee of the Company, or any of its affiliates or subsidiaries, to breach his or her employment agreement or to leave their employment;

 

5

 

iii.            Hale will not directly or indirectly attempt to encourage, induce or otherwise solicit, directly or indirectly, any business from, or attempt to sell, license, or provide the same or similar products or services as provided by the Company or any subsidiary of the Company to any customer of the Company; and

 

iv.            Hale will not call upon any prospective acquisition candidate, on Hale’s own behalf or on behalf of any person, which candidate was, to Hale’s knowledge after due inquiry, either called upon by the Company, or any of its affiliates or subsidiaries, or for which the Company made an acquisition analysis, for the purpose of acquiring such candidate.

 

(b)           The parties acknowledge that covenants and restrictions set forth in Sections 6 and 7 are necessary to protect the legitimate business interests of the Company.  The parties agree that, if the scope of enforceability of any or all the restrictive covenants set forth in this Agreement is in any way disputed at any time, a court may modify and enforce the covenants to the extent it believes to be reasonable under the circumstances existing at that time.

 

(c)           Hale agrees that the breach by him of Sections 6 and 7 could not reasonably or adequately be compensated in damages in an action at law, and that the Company shall be entitled to injunctive relief which may include, but shall not be limited to, restraining Hale from engaging in any activity that would breach this Agreement.  However, no remedy conferred by any of the specific provisions of Sections 6 and 7 (including this paragraph) is intended to be exclusive of any other remedy and each and every remedy shall be cumulative and shall be in addition to every other remedy given hereunder, or now or hereafter existing in law or in equity, or by statute or otherwise.  The election of any one or more remedies by the Company shall not constitute a waiver of the right to pursue other available remedies.

 

8.             Sufficient Time to Review.  A copy of this Agreement was delivered to Hale on October 13, 2011.  Hale acknowledges that he has been afforded a reasonable opportunity to consider this Agreement and is encouraged to consult with an attorney of his own choosing in deciding whether to execute this Agreement.  Hale acknowledges that he has been given a period of at least 21 days within which to consider this Agreement, and that he has read and fully understands the Agreement and enters into it freely, voluntarily, and without coercion, and in the event that he executes this Agreement in less than 21 days, his election to do so has been knowing and voluntary.

 

9.             Cooperation.         Hale agrees to fully cooperate with the Company in the investigation, defense or prosecution of any claims or actions now in existence or which may be brought in the future against or on behalf of the Company. Hale’s full cooperation in connection with such claims or actions shall include, but not be limited to, being available to meet with the Company counsel to prepare for trial or discovery or an administrative hearing or alternative dispute resolution and to act as a witness when requested by the Company at reasonable times designated by the Company. Hale also agrees to cooperate with the Company in the transitioning of his work and will be available to the Company for this purpose or any other purpose reasonably requested by the Company.

 

10.           Revocation Period.  Hale understands that he has a period of seven (7) days from the date he signs this Agreement to revoke this Agreement, and that, should he decide

 

6

 

to revoke it within said seven-day period, he shall not be entitled to the consideration recited herein.  Hale further understands that this Agreement shall not become effective or enforceable until the expiration of the seven-day period, and, therefore, that he shall not receive the consideration set forth herein until the revocation period has expired without Hale exercising his right of revocation. Hale agrees that he must provide written notice of revocation of this Agreement to Mark Strozik, Vice President, Human Resources, Summer Infant (USA), Inc., 1275 Park East Drive, Woonsocket, RI 02895, should he wish to exercise his rights to revoke this Agreement within the revocation period.  If this Agreement is not timely revoked, this Agreement will become effective as of the expiration of the revocation period (“Effective Date”).

 

11.           Termination of Change of Control Agreement.  The parties hereby agree that the Change of Control Agreement by and between the Hale and Summer Infant (USA), Inc. dated as of December, 2009, is terminated effective as of the Termination Date.

 

12.           Acknowledgement.  Hale acknowledges, represents and warrants that he enters into this Agreement knowingly, voluntarily, free of duress or coercion, and with a full understanding of all terms and conditions contained herein.

 

13.           Headings.  The headings are for convenience of the parties, and are not to be construed as terms and conditions of this Agreement.

 

14.           Severability. Should any provision in this Agreement be declared or determined to be illegal or invalid (with the exception of Section 4, in whole or in part, subsections included), the validity of the remaining parts, terms, or provisions shall not be affected and the illegal or invalid part, term, or provisions shall be deemed not to be part of this Agreement.

 

15.           Integration.  This Agreement constitutes the entire agreement between the parties, and supersede all oral negotiations and any prior and other writings with respect to the subject matter of this Agreement, and is intended by the parties as the final, complete and exclusive statement of the terms agreed to by them.

 

16.           Choice of Law.  This Agreement shall be governed by and construed in accordance with the laws of the State of Rhode Island.

 

17.           Amendment.  This Agreement shall be binding upon the parties and may not be amended, supplemented, changed, or modified in any manner, orally or otherwise, except by an instrument in writing of concurrent or subsequent date signed by the parties.

 

18.           Successors and Assigns.  This Agreement is and shall be binding upon and inure to the benefit of the heirs, executors, successors and assigns of each of the parties.

 

19.           Non-Admission.  This Agreement shall not in any way be construed as an admission by the Company that it has acted wrongfully with respect to Hale, and the Company specifically denies the commission of any wrongful acts against Hale.

 

20.           Non-Disparagement.  Hale agrees that he will not make any written or oral statement or take any action which he knows or reasonably should know constitutes an untrue,

 

7

 

disparaging, or negative comment concerning the Company.  The Company agrees that it will not make any written or oral statement or take any action which it knows or reasonably should know constitutes an untrue, disparaging, or negative comment concerning Hale.  If the Company’s Human Resources Department is contacted by prospective employers of Hale, the Company will provide only the starting and ending dates of Hale’s employment at the Company and the last position Hale held at the Company.  The Company also will advise any such prospective employers that it is the Company’s policy to release only such information.

 

21.           Reservation of Rights to Indemnification and Officer Liability Insurance for Actions Taken or Omitted While an Officer.  Hale’s right to indemnification to the fullest extent permitted by Rhode Island General Corporation Law and the Company’s Certificate of Incorporation and By-Laws for expenses (including attorney’s fees and disbursements), judgments, fines and amounts paid in settlement actually and reasonably incurred by Hale in connection with any proceeding arising by reason of acts taken or omissions to act occurring while Hale was an officer of the Company, shall continue unabridged after the Termination Date.

 

22.           Counterparts.  This Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original but all of which together constitute one and the same instrument.

 

[Remainder of Page Intentionally Left Blank]

 

8

 

IN WITNESS WHEREOF, the parties execute this Agreement as of the date indicated below.

 

 

	
 
    	
Summer Infant (USA), Inc.
    
	
 
    	
 
    
	
 
    	
 
    
	
/s/ Jeff Hale
    	
 
    	
By:
    	
/s/ Jason Macari
    
	
Jeff Hale
    	
Name:
    	
Jason Macari
    
	
 
    	
Title:
    	
President and Chief Executive Officer
    
	
 
    	
 
    
	
Date:
    	
10/17/2011
    	
 
    	
Date:
    	
October 17, 2011
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    
	
 
    	
Summer Infant, Inc
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Jason Macari
    
	
 
    	
Name:
    	
Jason Macari
    
	
 
    	
Title:
    	
President and Chief Executive Officer
    
	
 
    	
 
    
	
 
    	
Date:
    	
October 17, 2011

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00195-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00195-of-00352.parquet"}]]